vs
GoodRx Holdings, Inc.（GDRX）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
GoodRx Holdings, Inc.的季度营收约是Resolute Holdings Management, Inc.的1.7倍（$194.8M vs $117.7M），GoodRx Holdings, Inc.净利率更高（2.8% vs -1.5%，领先4.2%），Resolute Holdings Management, Inc.自由现金流更多（$189.2M vs $31.6M）
GoodRx是一家美国医疗健康企业，运营着远程医疗平台以及可免费使用的网站与移动应用，服务覆盖美国超75000家药店，可为用户追踪处方药价格、提供药品优惠折扣券，还支持用户在线问诊，获取部分品类药物的处方。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
GDRX vs RHLD — 直观对比
营收规模更大
GDRX
是对方的1.7倍
$117.7M
净利率更高
GDRX
高出4.2%
-1.5%
自由现金流更多
RHLD
多$157.6M
$31.6M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $194.8M | $117.7M |
| 净利润 | $5.4M | $-1.7M |
| 毛利率 | — | 55.7% |
| 营业利润率 | 11.6% | 30.2% |
| 净利率 | 2.8% | -1.5% |
| 营收同比 | -1.9% | — |
| 净利润同比 | -19.5% | — |
| 每股收益（稀释后） | $0.02 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GDRXRHLD
| Q4 25 | $194.8M | $117.7M | ||
| Q3 25 | $196.0M | $120.9M | ||
| Q2 25 | $203.1M | $119.6M | ||
| Q1 25 | $203.0M | $103.9M | ||
| Q4 24 | $198.6M | — | ||
| Q3 24 | $195.3M | — | ||
| Q2 24 | $200.6M | — | ||
| Q1 24 | $197.9M | — |
净利润GDRXRHLD
| Q4 25 | $5.4M | $-1.7M | ||
| Q3 25 | $1.1M | $-231.0K | ||
| Q2 25 | $12.8M | $-611.0K | ||
| Q1 25 | $11.1M | $-3.4M | ||
| Q4 24 | $6.7M | — | ||
| Q3 24 | $4.0M | — | ||
| Q2 24 | $6.7M | — | ||
| Q1 24 | $-1.0M | — |
毛利率GDRXRHLD
| Q4 25 | — | 55.7% | ||
| Q3 25 | — | 59.0% | ||
| Q2 25 | — | 57.5% | ||
| Q1 25 | — | 52.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率GDRXRHLD
| Q4 25 | 11.6% | 30.2% | ||
| Q3 25 | 7.5% | 34.3% | ||
| Q2 25 | 13.2% | 34.0% | ||
| Q1 25 | 11.5% | 24.7% | ||
| Q4 24 | 9.2% | — | ||
| Q3 24 | 10.5% | — | ||
| Q2 24 | 9.9% | — | ||
| Q1 24 | 3.7% | — |
净利率GDRXRHLD
| Q4 25 | 2.8% | -1.5% | ||
| Q3 25 | 0.6% | -0.2% | ||
| Q2 25 | 6.3% | -0.5% | ||
| Q1 25 | 5.4% | -3.2% | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | -0.5% | — |
每股收益（稀释后）GDRXRHLD
| Q4 25 | $0.02 | $-0.20 | ||
| Q3 25 | $0.00 | $-0.03 | ||
| Q2 25 | $0.04 | $-0.07 | ||
| Q1 25 | $0.03 | $-0.39 | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $0.01 | — | ||
| Q2 24 | $0.02 | — | ||
| Q1 24 | $0.00 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $261.8M | $205.5M |
| 总债务越低越好 | $495.0M | $169.8M |
| 股东权益账面价值 | $616.3M | $6.5M |
| 总资产 | $1.4B | $333.4M |
| 负债/权益比越低杠杆越低 | 0.80× | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资GDRXRHLD
| Q4 25 | $261.8M | $205.5M | ||
| Q3 25 | $273.5M | $148.0M | ||
| Q2 25 | $281.3M | $99.9M | ||
| Q1 25 | $301.0M | $71.0M | ||
| Q4 24 | $448.3M | — | ||
| Q3 24 | $423.8M | — | ||
| Q2 24 | $524.9M | — | ||
| Q1 24 | $533.3M | — |
总债务GDRXRHLD
| Q4 25 | $495.0M | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | $500.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益GDRXRHLD
| Q4 25 | $616.3M | $6.5M | ||
| Q3 25 | $600.7M | $10.8M | ||
| Q2 25 | $643.0M | $9.6M | ||
| Q1 25 | $654.3M | $8.9M | ||
| Q4 24 | $724.7M | — | ||
| Q3 24 | $696.4M | — | ||
| Q2 24 | $669.4M | — | ||
| Q1 24 | $631.1M | — |
总资产GDRXRHLD
| Q4 25 | $1.4B | $333.4M | ||
| Q3 25 | $1.3B | $293.2M | ||
| Q2 25 | $1.3B | $253.3M | ||
| Q1 25 | $1.3B | $214.3M | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.5B | — |
负债/权益比GDRXRHLD
| Q4 25 | 0.80× | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | 0.69× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $32.9M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | $31.6M | $189.2M |
| 自由现金流率自由现金流/营收 | 16.2% | 160.8% |
| 资本支出强度资本支出/营收 | 0.6% | 5.8% |
| 现金转化率经营现金流/净利润 | 6.06× | — |
| 过去12个月自由现金流最近4个季度 | $164.4M | $313.2M |
8季度趋势，按日历期对齐
经营现金流GDRXRHLD
| Q4 25 | $32.9M | $196.1M | ||
| Q3 25 | $76.0M | $59.6M | ||
| Q2 25 | $49.6M | $48.9M | ||
| Q1 25 | $9.4M | $18.4M | ||
| Q4 24 | $44.7M | — | ||
| Q3 24 | $86.9M | — | ||
| Q2 24 | $9.7M | — | ||
| Q1 24 | $42.6M | — |
自由现金流GDRXRHLD
| Q4 25 | $31.6M | $189.2M | ||
| Q3 25 | $74.3M | $58.6M | ||
| Q2 25 | $49.2M | $47.5M | ||
| Q1 25 | $9.3M | $17.8M | ||
| Q4 24 | $44.6M | — | ||
| Q3 24 | $86.5M | — | ||
| Q2 24 | $9.4M | — | ||
| Q1 24 | $42.2M | — |
自由现金流率GDRXRHLD
| Q4 25 | 16.2% | 160.8% | ||
| Q3 25 | 37.9% | 48.5% | ||
| Q2 25 | 24.2% | 39.7% | ||
| Q1 25 | 4.6% | 17.1% | ||
| Q4 24 | 22.4% | — | ||
| Q3 24 | 44.3% | — | ||
| Q2 24 | 4.7% | — | ||
| Q1 24 | 21.3% | — |
资本支出强度GDRXRHLD
| Q4 25 | 0.6% | 5.8% | ||
| Q3 25 | 0.9% | 0.8% | ||
| Q2 25 | 0.2% | 1.2% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.2% | — |
现金转化率GDRXRHLD
| Q4 25 | 6.06× | — | ||
| Q3 25 | 67.94× | — | ||
| Q2 25 | 3.86× | — | ||
| Q1 25 | 0.85× | — | ||
| Q4 24 | 6.64× | — | ||
| Q3 24 | 21.91× | — | ||
| Q2 24 | 1.45× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GDRX
| Prescription Transactions Revenue | $124.7M | 64% |
| Other | $44.4M | 23% |
| Subscription Revenue | $21.6M | 11% |
| Other Revenue | $4.1M | 2% |
RHLD
暂无分部数据
